In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand

NeuroReport

Volumn 9, Issue 10, 1998, Pages 2311-2317

  Vaupel, D Bruce ^a   Mukhin, Alexey G ^a   Kimes, Alane S ^a   Horti, Andrew G ^a   Koren, Andrei O ^a   London, Edythe D ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

5 I A 85380; Autoradiography; In vivo binding; Nicotine; Nicotinic acetylcholine receptor; Radiotracer

Indexed keywords

2 FLUORO 3 (AZETIDINYLMETHOXY)PYRIDINE F 18; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; IODINE 125; NICOTINIC RECEPTOR; PYRIDINE; RADIOLIGAND; TRACER; UNCLASSIFIED DRUG; AZETIDINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT; LIGAND; RADIOACTIVE IODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL LABELING; DIAGNOSTIC IMAGING; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MALE; METABOLISM; RADIOASSAY; SEIZURE; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; AZETIDINES; BEHAVIOR, ANIMAL; BRAIN; CHOLINERGIC ANTAGONISTS; IODINE RADIOISOTOPES; LIGANDS; MALE; MICE; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; SEIZURES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032513990     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199807130-00030     Document Type: Article

References (20)

1. Broussolle EP, Wong DF, Fanelli RJ et al. Life Sci 44, 1123-1132 (1989).
2. Flesher JE, Scheffel U, London ED et al. Life Sci 54, 1883-1890 (1994).
3. Clarke PBS, Schwartz RD, Paul SM et al. J Neurosci 5, 1307-1315 (1985).
4. London ED, Waller SB and Wamsley JK. Neurosci Lett 53, 179-184 (1985).
5. Swanson LW, Simmons DM, Whiting PJ et al. J Neurosci 7, 3334-3342 (1987).
6. Badio B and Daly JW. Mol Pharmacol 46, 563-569 (1994).
7. London ED, Scheffel U, Kimes AS et al. Eur J Pharmacol 278, R1-R2 (1995).
8. Horti A, Scheffel U, Stathis M et al. J Nucl Med 38, 1260-1265 (1997).
9. Ding Y, Gatley SJ, Fowler JS et al. Synapse 24, 403-407 (1996).
10. Musachio JL, Villemagne VL, Scheffel U et al. Synapse 26, 392-399 (1997).
11. Villemagne VL, Horti A, Scheffel U et al. J Nucl Med 38, 1737-1741 (1997).
12. Liu X, Musachio JL, Wagner HN Jr et al. Synapse 27, 378-380 (1997).
13. Sullivan JP, Decker MW, Brioni JD et al. J Pharmacol Exp Ther 271, 624-631 (1994).
14. Bannon AW, Decker MW, Holladay MW et al. Science 279, 77-80 (1998).
15. Scheffel U, Taylor GF, Kepler JA et al. NeuroReport 9, 2483-2488 (1995).
16. Sullivan JP, Donnelly-Roberts D, Briggs CA et al. Neuropharmacology 35, 725-734 (1996).
17. Marks MJ, Stitzel JA, Romm E et al. Mol Pharmacol 30, 427-436 (1986).
18. Flores CM, Rogers SW, Pabreza LA et al. Mol Pharmacol 41, 31-37 (1992).
19. Wada E, Wada K, Boulter J et al. J Comp Neurol 284, 314-335 (1989).
20. Slotnick BM and Leonard CM. A Stereotaxic Atlas of the Albino Mouse Forebrain. Rockville: US Government Printing Office, 1975.